Controlled Three-Dimensional Tumor Microenvironments Recapitulate Phenotypic Features and Differential Drug Response in Early vs Advanced Stage Breast Cancer.

Singh, Manjulata; Venkata Krishnan, Harini; Ranganathan, Supraja; Kiesel, Brian; Beumer, Jan Hendrik; Sreekumar, Sreeja; Sant, Shilpa

Singh, Manjulata; Venkata Krishnan, Harini; Ranganathan, Supraja; Kiesel, Brian; Beumer, Jan Hendrik; Sreekumar, Sreeja; Sant, Shilpa.

Afiliación

Kiesel B; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15232, United States.
Beumer JH; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15232, United States.
Sreekumar S; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, United States.
Sant S; Department of Pharmacology and Chemical Biology, Women's Cancer Research Center, Magee-Women's Research Institute, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15232, United States.

ACS Biomater Sci Eng ; 4(2): 421-431, 2018 Feb 12.

Article en En | MEDLINE | ID: mdl-33418733

Palabras clave

EGFR/VEGF targeted therapy; breast cancer progression; endocrine resistance; in vitro drug screening; size-controlled microtumor model; three-dimensional in vitro models

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: ACS Biomater Sci Eng Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google